Merck & Co. said Monday it has entered a five-year collaboration with NGM Biopharmaceuticals to research and develop drugs that treat diabetes and obesity.
via WSJ.com: US Business http://ift.tt/1JCZxgx
via WSJ.com: US Business http://ift.tt/1JCZxgx
Nessun commento:
Posta un commento